29 results
PRE 14A
AXLA
Axcella Health Inc.
7 Aug 23
Preliminary proxy
4:15pm
: ASND) from April 2008 to June 2011, advancing the company’s portfolio of new, innovative prodrugs from discovery to clinical proof-of-concept … of Cardiovascular, Renal and Metabolic Diseases Innovative Medicines and Early Development. Dr. Rondinone served in different roles in research and development
8-K
AXLA
Axcella Health Inc.
13 Oct 22
Entry into a Material Definitive Agreement
8:15am
Review and Compensation Committees. Mr. Rosiello led the work that shifted McKinsey’s recruiting toward non-MBAs and developed innovative leadership … 2011, advancing the company’s portfolio of new, innovative prodrugs from discovery to clinical proof-of-concept. Earlier, Mr. Straight Nissen served
8-K
EX-99.1
to6gl6d1u84j8k
3 Mar 21
Axcella Announces Alison D. Schecter, M.D., as President of R&D
5:26pm
DEF 14A
ujw2 ks5zatiidco7yu
3 Apr 20
Definitive proxy
4:15pm
10-K
2v5dbtykqkkt5j7qv 1b
23 Mar 20
Annual report
4:12pm